17 September 2018 | News
Global giants Bayer, Merck, and GE Ventures will be coming on aboard, and will collaborate with H. Spectrum.
Image credit- bostonmagazine.com
Asia's largest biomedical accelerator, H. Spectrum is planning to collaborate with five major companies on a range of innovative medical technologies. This announcement was made during the Trans 2018 digital health conference held in Taipei on September 8-9.
Global giants Bayer, Merck, and GE Ventures will be coming on aboard, and will collaborate with H. Spectrum on applications of artificial intelligence, and to explore new opportunities with U.S. tech company NVIDIA.
H. Spectrum has signed the strategic partnership during the Trans 2018 digital health conference, which was organized by H. Spectrum and Foxconn. The conference brought together some of the world's most influential biomedical, venture capital, and medical companies.